Summary
- Profile Type
- Business Offer
- POD Reference
- BOUA20231218003
- Term of Validity
- 18 December 2023 - 17 December 2025
- Company's Country
- Ukraine
- Type of partnership
- Commercial agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
-
Our Distinctive Features: Specialized medical facility. Specialization in the treatment of neurological and psychiatric disorders in children.
Two Focus Areas: Neurology, Psychiatry, Unique hardware treatment using advanced technology(TRANSCRANIAL PULSE STIMULATION (TPS)NEUROLITH®, Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), magnetic stimulation of the peripheral nervous system, Neurofeedback) - Full Description
-
More about Our Methods:
TRANSCRANIAL PULSE STIMULATION (TPS)
Transcranial Pulse Stimulation (TPS) is the latest and most advanced non-invasive brain stimulation technique. In 2018, Transcranial Pulse Stimulation (TPS) using the NEUROLITH® system received approval for treating the central nervous system in patients with Alzheimer's disease, making it the only method of its kind to date.
Key Features of TPS Therapy:
6-8 TPS sessions
Each session lasts approximately 30 minutes
Non-invasive, safe, and straightforward procedures
No need to shave the head
Significant neuropsychological improvement
Antidepressant effect
Which Conditions Can Be Treated with TPS?
Dementia:
Alzheimer's disease
Frontotemporal dementia
Dementia in Parkinson's disease
Mild cognitive impairment
Other Neurological Disorders:
Parkinson's disease
Spinocerebellar ataxia type 1 (SCA1)
Aphasia
Corticobasal degeneration
Post-stroke rehabilitation
Motor and sensory neuropathies
Alzheimer's Disease and TPS Treatment
Transcranial Pulse Stimulation (TPS) is a therapeutic method approved in Europe since 2018 for treating Alzheimer's disease in mild and moderate-severe forms. TPS aims to improve cognitive abilities in people with Alzheimer's dementia by stimulating various areas of the brain and maintaining this state for as long as possible. Patients and their families have reported improvements in verbal abilities, memory, spatial orientation, and a reduction in symptoms of accompanying depression.
TMS
Transcranial Magnetic Stimulation (TMS) is a safe therapeutic method based on the use of magnetic fields and electromagnetic induction phenomena to correct brain neuron activity. It offers an alternative treatment for certain psychiatric and neurological disorders, especially those resistant to medication.
TMS therapy has been officially approved for use by the U.S. Food and Drug Administration (FDA), known for its stringent regulations, as well as the National Institute for Health and Care Excellence (NICE) in the United Kingdom. TMS therapy is widely available and recommended in many leading countries around the world.
How Does TMS Work?
TMS enhances the neuroplasticity of brain tissue by releasing neuroprotective substances and neurotransmitters (such as serotonin) in the brain. Transcranial magnetic stimulation also stimulates the formation of new neural connections. - Advantages and Innovations
- Unique hardware treatment using advanced technology.
- Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
Partner Sought
- Expected Role of a Partner
- We are looking forward for potential partnership for expanding the clinic and its capabilities (equipment, accredited testing in Ukrainian, joint research, etc.)
- Type and Size of Partner
- SME 50 - 249
- SME 11-49
- SME <=10
- University
- Big company
- Other
- Type of partnership
- Commercial agreement
Dissemination
- Technology keywords
- 06001012 - Medical Research
- Market keywords
- 05005008 - Internal medicine
- 05002005 - Other medical imaging
- 05004001 - Electromedical and medical equipment
- 005001002 - Medical imaging
- Targeted countries
- All countries